Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |